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end of life: A national post-bereavement 
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Abstract
Background: Family members provide vital care at end of life, enabling patients to remain at home. Such informal care contributes 
significantly to the economy while supporting patients’ preferences and government policy. However, the value of care-givers’ 
contributions is often underestimated or overlooked in evaluations. Without information on the activities and expenditures involved 
in informal care-giving, it is impossible to provide an accurate assessment of carers’ contribution to end-of-life care.
Aim: The aim of this study was to investigate the contributions and expenditure of informal, family care-giving in end-of-life cancer care.
Design: A national census survey of English cancer carers was conducted. Survey packs were mailed to 5271 people who registered 
the death of a relative to cancer during 1–16 May 2015. Data were collected on decedents’ health and situation, care support given, 
financial expenditure resulting from care, carer well-being and general background information.
Results: In all, 1504 completed surveys were returned (28.5%). Over 90% of respondents reported spending time on care-giving in 
the last 3 months of the decedent’s life, contributing a median 69 h 30 min of care-giving each week. Those who reported details of 
expenditure (72.5%) spent a median £370 in the last 3 months of the decedent’s life.
Conclusion: Carers contribute a great deal of time and money for day-to-day support and care of patients. This study has yielded a 
unique, population-level data set of end-of-life care-giving and future analyses will provide estimates of the economic value of family 
care-givers’ contributions.
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What is already known about the topic?
•• Family carers make a substantial contribution to end-of-life care, but few studies have considered the hours of care-giving 
provided and carers’ out-of-pocket expenditure.
•• Estimates of end-of-life care-giving contributions and/or out-of-pocket expenditures are mainly derived from studies that 
are either small in size or lack detailed information on this issue.
What this paper adds?
•• This study is the first to provide population-based information on the scale of cancer-related carer activity and out-of-
pocket expenditures to enable the economic value of carers’ contribution to end-of-life care to be calculated.
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•• We have collected detailed data directly from carers using a bespoke census survey, overcoming many limitations of 
previous work.
•• We find that carers’ contribution to end-of-life care is substantial and could be much higher than some previous esti-
mates suggest.
Implications for practice, theory or policy
•• These data provide important information for policy makers and service planners who should take into account carers’ contri-
butions, both in terms of hours worked and out-of-pocket expenditure, and the value of these contributions to the economy.
Introduction
A majority of patients prefer to stay at home at the end of 
life1 and government policy supports this choice.2 For 
many people with cancer, the final period of illness is char-
acterised by increasingly complex and intense care needs.3 
Family members often take on prolonged caring roles and 
are pivotal to ensuring that patients’ needs are met.4 
Without family support, many people would be unable to 
remain at home in their final illness.5,6 Indeed, national-
level data from countries worldwide indicate that married 
patients are able to die at home more frequently than those 
who are divorced, widowed or unmarried, indicating the 
importance of family carers.7,8
The scale of family members’ contribution and the 
financial burden on families are often overlooked in con-
siderations of end-of-life caring although costs and conse-
quences may be profound.9,10
Support for carers was explicitly excluded from the 
NHS Palliative Care Tariff recommended by the 
Palliative Care Funding Review 4 (PCFR) for England, 
despite its emphasis on enabling patient death at home.2 
The National End of Life Care Programme (NEnd-of-
lifeCP)11 identified critical success factors that enable 
people to die in their preferred place of death, but omit-
ted family carers from the list, despite empirical evi-
dence that carers play a crucial role in this respect.5 
NEnd-of-lifeCP12 estimated end-of-life community care 
to be cheaper than acute hospital care, but this calcula-
tion only considered health and social care costs, not 
carers’ contribution. Evidence syntheses suggest that 
palliative care is cheaper than standard care, but carers’ 
time and out-of-pocket costs are consistently excluded 
from economic evaluations.13,14
Within the current literature, important aspects relating 
to carer contributions (hours of care given, type of task and 
out-of-pocket expenditure) are routinely omitted from esti-
mates, or where they are included, samples are small and 
unrepresentative. Specifically for UK cancer carers, much 
evidence has been from analysis of secondary data, which 
were not designed to consider these issues in detail, and has 
omitted both carer time and out-of-pocket expenditure.15–17 
Round et al.18 estimated that informal care during the end-
of-life period (defined as time since patient began using 
strong opioids – 243 days) equates to £3265 GBP per 
patient (approximately $4641USD). However, this relied 
on secondary data, where out-of-pocket or other expenses 
were not included. Some international studies have included 
carer time and out-of-pocket expenditure in their estima-
tions of the value of carers’ contributions. Van Houtven 
et al.19 estimated the value of 24.5 h of care per week at 
$2164USD per month per patient (approximately 
£1774GBP/$2877CAD). This estimate was calculated at 
2005 prices and does not account for inflation. Based on 
more recent data, estimates have valued care hours at 
$5077CAD20 and $11334CAD21 per patient per month 
(app roximately £3148GBP/$3808USD (2012 data);20 
£7027GBP/$8501USD (2011 data)21 (number of care hours 
not defined)), while monthly out-of-pocket expenditure 
ranged from $209USD19 to $839CAD20 (approximately 
£171GBP/$278CAD–£520GBP/$629USD). However, 
these studies were small scale (n = 129;21 n = 138;20 n = 14419) 
and not based on nationally representative data.
While the above studies provide much needed esti-
mates, they all have limitations, and comprehensive fig-
ures for informal carer contributions and their associated 
economic value are still absent from the literature. This 
could lead to cost-shifting and overburdening of family 
and friends, ultimately compromising care quality.22 While 
broad population estimates of hours of care exist for carers 
in general,23 the intensity of end-of-life care-giving 
demands specific consideration. As a first step to address 
the need for comprehensive information on family care 
contributions at end of life, and given the predominance of 
cancer within palliative care literature, we focus our 
research on cancer care.
In this article, we report data from a population-based 
study of cancer-related family care-giving activity at end of 
life in England. Working with the Office for National 
Statistics (ONS), we are uniquely able to report a compre-
hensive national overview of carers and their care-giving 
context, detailed information on the time spent on care 
tasks during patients’ last 3 months of life and out-of-pocket 
expenditure. This extensive data set will form the basis for 
future, more in-depth analyses of the economic value of 
carers’ contributions, impact of care-giving on carers’ situ-
ation and well-being, and factors related to these.
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Methods
Design
Post-bereavement, cross sectional and national postal 
survey.
Sample
The ONS drew a census sample of everyone (5271 people) 
who registered a cancer death in England over a 2-week 
period, that is, 1–16 May 2015. Unlike other causes of 
death, cancer does not display seasonal variation24,25 and 
ONS data show no variation in cancer deaths by day of 
week or time of month.26 Dates were chosen to avoid other 
ONS post-bereavement surveys while allowing appropri-
ate time post-bereavement for those contacted.
Inclusion criteria were as follows: death occurred dur-
ing the designated period, in England, was caused by can-
cer (International Classification of Diseases, 10th revision 
(ICD)-10 codes C000-C979) and the decedent was aged 
over 18 years. Exclusion criteria were as follows: death 
occurred somewhere other than home, hospital, care home 
or hospice, was reported to the coroner, the person who 
registered the death was not a relative, the address of the 
person registering the death was missing, or sex or age of 
deceased was missing.
The University of Manchester’s Research Ethics 
Committee approved the study (Ref: 14430).
Procedure
The research team worked with the ONS team, carer 
groups and bereaved individuals to develop the survey 
content and ensure materials were sensitive, relevant and 
understandable. This included discussing content and for-
matting with a lay end-of-life research advisory group, 
carer cognitive-debriefing interviews (n = 5) and pilot sur-
veys (n = 19).
ONS mailed surveys to the identified sample. No per-
sonal information was shared with the research team. 
People received (1) personalised covering letter (name, 
address, name of decedent), (2) information sheet empha-
sising the option to decline and avoid reminders, (3) 
decline slip, (4) survey and (5) reply-paid return enve-
lope to the research team. Survey packs were sent to the 
person registering the death, who was invited to pass the 
survey to the person who provided most care, if 
appropriate.
Surveys were mailed to participants 4 months after reg-
istering a death (September 2016). Non-responders (no 
survey or decline slip returned) were sent a reminder letter 
1 month later and another full survey the following month.
Participants could respond via online survey or tele-
phone interview. Large print or non-English version of the 
survey was available on request.
Questionnaire
Questions were predominantly closed, single response 
from multiple choices. We report here the following items:
1. General background. Demographic information, 
work status, and relationship and proximity to the 
decedent.
2. Decedent’s health and situation. Date and type of 
diagnosis.
3. Carer contribution – care tasks. Types of care tasks 
were presented under the headings: household 
tasks (six items), personal care (one item), health 
care and medicine (two items) and social and emo-
tional care (one item). Participants estimated how 
much time (hours:minutes) they spent on each task 
in a typical week in the last 3 months of the dece-
dent’s life. The list was derived from survey devel-
opment work and previous publications.27–29 
Participants were instructed not to count any activ-
ity twice and to write ‘0’ if they had not done a 
particular task.
We conceptualised care-giving as any task the par-
ticipant undertook which provided care and/or assis-
tance. While many respondents may have been the 
patient’s spouse and may therefore have undertaken 
some tasks as part of this role, distinct from the impact 
of illness, we reasoned that had the spouse been unable 
to perform those tasks, then the state/another person 
would have to fulfil those duties. Given this logic, we 
incorporated all associated care-giving tasks within our 
estimates.
4. Carer contribution – Out-of-pocket expenditure. 
Participants were asked to estimate financial 
expenditure resulting from care provision for the 
decedent during the last 3 months of life. Items 
were presented under the headings: help from oth-
ers, social activity and direct expenses. Details 
about any large, one-off expenses as a result of 
diagnosis (i.e. moving home) were also collected.
ONS provided anonymised data for the whole sampling 
frame linked by study identification (Study ID) number on 
the following variables: age and sex of deceased, date of 
death, date of death registration, final underlying cause of 
death by ICD-10 codes, place of death and index of multi-
ple deprivation (IMD).30
Analysis
Analyses were conducted using SPSS v22.31 Descriptive 
data are presented for respondent and decedent character-
istics, types of care tasks and time taken, and care-related 
expenditure. Differences between decedent demographics, 
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as supplied by ONS, were explored by response type 
( survey, decline, no response) using chi-square for cate-
gorical variables and analysis of variance (ANOVA) for 
continuous data. Due to non-homogeneous variance (indi-
cated by Levene’s statistic), the Brown–Forsythe F statis-
tic is reported for ANOVAs as it is robust to violations of 
this assumption. Post hoc comparisons of significant chi-
square tests were made using z-tests to compare column 
proportions, with Bonferroni adjustment for multiple test-
ing. The responder by cancer type chi-square had expected 
frequencies <5 in 12.8% of cells, which was acceptable 
given the large number of variables.32
These data did show evidence of non-normality (skew 
and kurtosis) but as sample sizes were large and groups 
roughly equal data were not transformed to achieve 
 normality.32 We did not make adjustments where data were 
missing, but have reported the number of missing values 
within the tables. We refer to median values throughout the 
results unless otherwise specified.
Results
Response rates
Surveys were completed by 28.5% (n=1504), 1851 
(35.1%) declined to participate and n=1915 (36.3%) made 
no response.
Table 1 presents the differences in response rates and 
shows statistically significant differences in demographic 
characteristics of decedents between those who completed 
the survey (participants/responders), those who declined 
and those who made no response. Participants were signifi-
cantly more likely to have registered the death of someone 
who died at home (35.9%; 29.6% non-responders, 28.1% 
decliners), who was older (76 years) than for non-respond-
ers (74 years) and younger than for decliners (78 years). 
Participants were also significantly more likely to be from 
less deprived areas (IMD 5: 24.6% participants, 19.9% 
decliners, 14.9% non-responders). There was no significant 
difference in the cancer site of decedent by responder group.
Participant characteristics
The majority of participants were female (64.2%), White 
(95.7%), with a median age of 60 years (mean: 60.4 (SD: 
12.28)) and were qualified at school-leaver level (16 years) 
or higher (74.4%; Table 2).
Just under half of participants (44.5%) were the spouse/part-
ner of the decedent and many had cared for their parent (43.2%). 
Half of decedents and respondents lived together (50.6%) and 
33.7% lived within a 30-min journey of each other. A majority 
of participants (53.7%) were employed and 36.4% were retired 
when the decedent first became ill (Table 3).
In the last 3 months of life, three-quarters (75.3%) of 
decedents were ‘usually resident’ at home, 9.7% were 
‘usually resident’ in hospital, 7.0% in care home, 2.3% in 
hospice (2.3%) and 2.8% in other locations (e.g. sheltered 
accommodation, someone else’s home, palliative care 
unit; Table 3).
Contributions and costs of care-giving
During the last 3 months of life, 90.0% of participants 
reported spending time on care-giving which is 99.1% of 
those who responded to this question. These carers spent a 
median total of 69 h 30 min each in a typical week on care-
giving – representing a mean of 9:56 h/day, every day of a 
typical week (Table 4).
The majority of participants (82.9%) reported provid-
ing social and emotional support, for a median of 20 h/
week. This was followed by shopping (79.1%; 3 h), clean-
ing (72.7%; 7 h) and preparing food and drink (72.1%, 
10 h). Fewest participants helped with maintenance and 
odd jobs (55.3%, 3 h).
In total, 76.1% of participants reported out-of-pocket 
expenditure which arose as a result of care-giving in the 
last 3 months of life (Table 5). Not everyone who reported 
a cost gave expenditure amount and as such data in Table 5 
are calculated including only those who supplied figures 
(72.5%).
The most frequent expenditure was for travel expenses 
(47.9%) at a median cost of £100 per person over the last 3 
months of life, followed by expenditure on meals and 
snacks while out with the patient (42.0%, £50), medical 
equipment and care supplies (25.1%, £100), and increased 
household bills (24.1%, £129). The biggest expenditure 
was nursing home/private care home (4.9%, £2000). 
Participants had a median total of £370 of out-of-pocket 
expenditure during the last 3 months of care-giving.
Additionally, 16.9% had ‘one-off expenses’ during their 
whole time care-giving. The median reported cost was 
£2000 and included payment for car, mobility equipment, 
furniture, house adaptations, cashing endowments/draw-
ing on house capital, private medical care – including 
Swiss clinics/‘Dignitas’ and funeral costs.
Discussion
Our study provides national estimates of the contributions 
and out-of-pocket expenditure of family care-giving at 
end of life using a census survey completed by recently 
bereaved cancer carers.
Furthermore, our methods demonstrate that it is feasi-
ble to retrospectively collect very detailed data on carers’ 
contributions and that carers find this acceptable. A sub-
stantial proportion of those we approached made some 
response to the survey invite (63.7%). Those who reported 
the death of a younger person and who were from more 
disadvantaged areas were less likely to respond, which is 
commensurate with survey response theory.33
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Non-surprisingly, almost all participants provided 
informal care in a typical week in the last 3 months of 
life. The median hours of care provided by each indi-
vidual totalled 69:30 h (almost 10 h/day) and 25% of 
participants provided 115:15 h of care, or more, per 
week; over 16 h/day.
The main type of care provided was social/emotional 
support. The majority reported contributing to the very 
practical tasks of everyday living and to the medical care 
of the patient. Those who helped with personal care spent 
a high number of hours doing so. These data were sup-
plied as a ‘typical’ week; a greater volume and intensity 
of care may occur in the final weeks or days before death. 
We also hypothesise that intensity of care-giving would 
vary by care-giver context and we plan to explore this in 
future analyses. Round et al.18 estimate informal care 
provision of 15 h/week and Van Houtven et al.19 estimate 
24.5 h. Given the number of hours of care identified in 
our study, the financial value of care-giving is likely to be 
greater than these estimates, even without out-of-pocket 
expenditure.
Fewer people reported out-of-pocket expenditure than 
care tasks, but the expenditure reported facilitated vital 
care for patients. For example, to provide care 50.6% 
incurred costs travelling, 44.6% spent money on suste-
nance while they were doing this and 25.1% spent money 
Table 1. Differences in decedent characteristics between responders, non-responders and decliners (N = 5270a).
Total sample Non-responders Responders Decliners Test (df) p value
n 5271 1915 1504 1851  
Patient age (years) (SD) 74.41 (12.27) 72.56 (12.5)A 74.36 (12.4)B 76.35 (11.6)C Fb (25,087) = 45.58 <0.001
Median (min–max) (SD) 76 (18–102) 74 (18–99) 76 (19–100) 78 (25–102)  
Patient gender χ2 = 5.254 (2) 0.072
 Males 2775 (52.6) 969 (50.6) 802 (53.3) 1003 (54.2)  
Place of death χ2 = 40.989 (6) <0.001
 Hospital 1863 (35.3) 715 (37.3)A 448 (29.8)B 699 (37.8)A  
 Care home 766 (14.5) 256 (13.4)A 219 (14.6)A 291 (15.7)A  
 Home 1627 (30.9) 566 (29.6)A 540 (35.9)B 521 (28.1)A  
 Hospice 1015 (19.3) 378 (19.7)A 297 (19.7)A 340 (18.4)A  
Multiple indices of deprivation 
(decedent)
χ2 = 126.384 (8) <0.001
 1 (most deprived) 1059 (20.1) 491 (25.6)A 204 (13.6)B 363 (19.6)C  
 2 981 (18.6) 407 (21.3)A 255 (17.0)B 319 (17.2)B  
 3 1146 (21.7) 388 (20.3)A 335 (22.3)A 423 (22.9)A  
 4 1062 (20.1) 344 (18.0)A 340 (22.6)B 378 (20.4)A,B  
 5 (least deprived) 1023 (19.4) 285 (14.9)A 370 (24.6)B 368 (19.9)C  
Primary cause of death: cancer site 
(ICD-10 classification)
χ2 = 60.004 (50) 0.157
 Lung (C33–34) 1139 (21.6) 444 (23.2) 302 (20.1) 393 (21.2)  
 Colorectal (C18–20) 499 (9.5) 161 (8.4) 152 (10.1) 186 (10.0)  
 Prostate (C61) 401 (7.6) 134 (7.0) 119 (7.9) 147 (7.9)  
 Breast (C50) 375 (7.1) 143 (7.5) 110 (7.3) 122 (6.6)  
 Pancreas (C25) 284 (5.4) 110 (5.7) 82 (5.5) 92 (5.0)  
 Oesophagus (C15) 265 (5.0) 76 (4.0) 93 (6.2) 96 (5.2)  
  All other malignant cancers  
(excl. C44)c
2308 (43.8) 847 (44.2) 646 (42.9) 815 (44.0)  
NB: un-matching subscripts (along the row) (e.g. A, B) denote statistically significant difference, whereas matching subscripts denote no significant 
difference (e.g. A, A).
Values are represented in frequencies (%) or means and standard deviations.
aDue to researcher error, one participant’s response status could not be determined (non-response or decline). Therefore, their ONS-linked data 
were excluded from analyses by response type as it could not be attributed to a response category. However, their data are included in descriptives 
of the sample overall.
bMean (SD). Browne–Forsythe statistic reported due to non-homogeneity of variance.
cAnalysis was conducted by individual cancer category. The largest groups are detailed and other cancer types are presented as a summery category 
‘All other …’ for conciseness. Includes other cancer categories – lip oral and pharynx, C00–14; stomach, C16; liver, C22 and C25; larynx, C32; 
melanoma of skin, C43; skin (other malignant neoplasm), C44; mesothelioma, C45; cervix, C53; uterus, C54–55; ovary, C56–57.4; testis, C62; 
kidney, C64–66 and 68; bladder, C67; brain, including other central nervous system (CNS) and intracranial tumours, C70–72, C75.1–C75.3, D32–
D33, D35.2–D35.4, D42–D43, D44.3–D44.5; thyroid, C73; Hodgkin’s disease, C81; non-Hodgkin’s lymphoma, C82–85; multiple myeloma, C90; 
leukaemia, C91–95; and all other malignant cancers.
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on medical equipment and care supplies in addition to 
those supplied by the National Health Service. Participants 
also reported spending money on one-off costs which may 
have included care home expenses, house moves or funer-
als. In adopting a wide definition of care-related costs, 
such as these, a comprehensive picture of the types of 
financial expenditure that families are exposed to emerges. 
Although some of these costs may be seen as outside the 
remit of care-giving (e.g. funeral expenses), ultimately, 
these costs are often borne by the family of the dying per-
son and may form part of the contribution a carer makes to 
support a dying person.
It has been estimated that out-of-pocket expenditure 
in the last month of life could total $379CAD (approxima - 
tely £235GBP/$284USD)21 or $839CAD(approximately 
£520GBP/$629USD).20 Converted to a 3-month esti-
mate of £705, or £1561, these figures are much higher 
than the £370 we report over 3 months. Differences 
between the Canadian and UK health systems are likely 
to lead to different resource needs for carers which may 
explain some variation in out-of-pocket expenditure 
reported (e.g. insurance payments). This expenditure 
represents a sizable contribution to the care-giving pro-
cess and may have a considerable negative impact for 
those who incur these costs.
Implications and recommendations
Informal care-giving represents a substantial contribu-
tion to society and is vital to the provision of end-of-life 
care. However, many informal care-givers would be 
unwilling to provide care again.34 It is therefore essen-
tial that appropriate support, particularly palliative sup-
port, is available for family members to ensure the 
continued provision of care.35 Our data indicate that car-
ers provide care beyond the safe working hours recom-
mended to preserve health and well-being.36 It behoves 
us as a society to support informal care-givers, provide 
respite when needed and otherwise ensure that hours of 
care-giving entail the minimum distress and strain. 
Given the hours that informal care-givers invest in care, 
and subsequent savings to society, society should invest 
in them.
Our work suggests that economic analyses of interven-
tions and location of care should, as a matter of course, 
include contributions given by care-givers in terms of time 
Table 2. Participant characteristics (N = 1504).
Frequency (%)
Age (years) (missing n = 24 (1.6%))
Mean (SD) 60.4 (12.28)
Median (min-max) 60 (21–94)
Gender
 Male 517 (34.4)
 Female 966 (64.2)
 Missing 21 (1.4)
Ethnicity
 White 1439 (95.7)
 Mixed/multiple ethnic group 7 (0.5)
 Asian/British Asian 16 (1.1)
 Black/African-Caribbean/Black British 7 (0.5)
 Other ethnic group 6 (0.4)
 Missing 29 (1.9)
Educational level
 None 226 (15.0)
 Exams at 16 years/equivalent 405 (26.9)
 ‘A’/‘AS’ Levels/college/equivalent 334 (22.2)
 University degree 381 (25.3)
 Other 51 (3.4)
 Missing 107 (7.1)
Mode of response
 Paper 1395 (92.8)
 Online 88 (5.9)
 Telephone 21 (1.4)
Frequencies (%) unless otherwise stated.
Table 3. Care-giving context (n = 1504).
Frequency (%)
Decedent’s relationship to respondent
 Spouse/partner 669 (44.5)
 Parent 650 (43.2)
 Someone else 157 (10.4)
 Missing 28 (1.9)
Proximity to decedent
 In the same house 761 (50.6)
 Within walking distance 145 (9.6)
 Within 10-min drive/bus or train journey 177 (11.8)
 Within 30-min drive/bus or train journey 185 (12.3)
 Within 1-h drive/bus or train journey 77 (5.1)
 Over 1-h drive/bus or train journey 142 (9.4)
 Missing 17 (1.1)
Decedent’s primary location in last 3 months of life
 Home 1133 (75.3)
 Hospice 34 (2.3)
 Hospital 146 (9.7)
 Care home 105 (7.0)
  Other (including combinations of above  
categories)
42 (2.8)
 Missing 44 (2.9)
Employment status when decedent became ill
 Employed full time 488 (32.4)
 Employed part time 202 (13.4)
 Self-employed 118 (7.8)
 Homemaker 45 (3.0)
 Unemployed 25 (1.7)
 Retired 548 (36.4)
 Other 59 (3.9)
 Missing 19 (1.3)
Frequencies (%) unless otherwise stated.
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and expenditure and our data provide a basis for economic 
estimates of carer contributions. We adopted, and would 
recommend, a strong programme of participant engage-
ment in the development of further economic evaluation 
work in order to maximise response rates among this vul-
nerable group.
Strengths and limitations
To our knowledge, this study is the first to provide detailed 
population-based information on the scale of cancer-
related care activity and its contribution to end-of-life care. 
We collected data directly from respondents, using a 
Table 4. Time spent on care-giving tasks in a typical week in last 3 months of life (n = 1504) (hours:minutes – calculations based 
on ‘n responded > 0’).
n responded  
‘0 h’ (%)
n responded  
> ‘0 h’ (%)
Mean (SD) Median Inter-quartile 
range (25–75)
Missing n (%)
Household tasks
 Preparing food and drink 163 (10.8) 1084 (72.1) 13:30 (27:47) 10:00 04:45–14:30 257 (17.1)
 Cleaning 159 (10.6) 1093 (72.7) 10:51 (24:09) 07:00 03:00–14:00 252 (16.8)
 Maintenance/odd jobs 307 (20.4) 831 (55.3) 04:55 (08:29) 03:00 01:30–06:00 366 (24.3)
 Shopping 84 (5.6) 1190 (79.1) 05:23 (21:38) 03:00 02:00–06:00 230 (15.3)
 General administration 159 (10.6) 1084 (72.1) 04:02 (09:52) 02:00 01:00–04:00 261 (17.4)
 Travelling with patient 286 (19.0) 876 (58.2) 07:09 (18:56) 04:00 02:00–08:00 342 (22.7)
 Personal care 231 (15.4) 956 (63.6) 14:07 (22:47) 07:00 03:00–14:00 317 (21.1)
Organising/attending appointments 148 (9.8) 1069 (71.1) 06:14 (12:37) 03:00 02:00–07:00 287 (19.1)
Helping with symptoms 169 (11.2) 1047 (69.6) 11:52 (30:01) 05:00 02:00–10:00 288 (19.1)
Social and emotional support 26 (1.7) 1247 (82.9) 36.03 (54:25) 20:00 08:00–40:00 231 (15.4)
Other 177 (11.8) 153 (10.20) 21:23 (42:20) 06:00 02:30–14:00 1174 (78.1)
Total time spent on care-giving 12 (0.8) 1353 (90.0) 94:59 (123:15) 69:30 28:37–115.15 139 (9.2)
Table 5. Money spent as a result of care-giving (n = 1504) (£GBP – calculations based on ‘n responded > 0’).
Indicated  
n^ (%)
Reported  
n+ (%)
Mean (SD) Median Inter-quartile 
range (25–75)
Missing n (%)
In last 3 months of life
 Help from others
  Nursing home/private care home 82 (5.5) 74 (4.9) 3138.58 (3384.28) 2000.00 487.50–5000 1422 (94.5)
  Privately employing nurse/carer 67 (4.5) 63 (4.2) 1785.90 (2979.05) 500.00 160–1500 1437 (95.5)
  Child care 22 (1.5) 21 (1.4) 545.90 (566.73) 400.00 100–852 1482 (98.5)
  Odd jobs not normally paid for 250 (16.6) 244 (16.2) 371.74 (901.14) 150.00 60–337.5 1254 (83.4%)
 Respite/holidays/day trips 129 (8.6) 125 (8.3) 780.08 (1085.06) 350.00 150–1000 1375 (91.4)
Direct expenses
 Medical equipment/care supplies 390 (25.9) 377 (25.1) 289.10 (907.79) 100.00 50–200 1114 (74.1)
 Prescription/non-prescription drugs 128 (8.5) 119 (7.9) 107.47 (279.26) 30.00 20–80 1376 (91.5)
 Household bills 410 (27.3) 363 (24.1) 235.62 (395.03) 129.00 80–300 1094 (72.7)
 Travel expenses 760 (50.6) 720 (47.9) 208.20 (424.17) 100.00 48.5–207.5 744 (49.5)
 Meals/snacks while out 670 (44.6) 631 (42.0) 113.10 (213.40) 50.00 30–100 834 (55.5)
 Extra food/supplements/vitamins 323 (21.5) 296 (19.7) 123.03 (313.98) 55.00 30–120 1181 (78.5)
 Other 194 (12.8) 179 (11.9) 602.27 (1481.12) 150.00 60–400 1310 (87.1)
 Total spend (sum)a – 1090 (72.5) 1025.00 (2024.75) 370.00 150–919 414 (27.5)
Any time since diagnosis
 One-off expense 254 (16.9) 240 (16.0) 8759.84 (44902.50) 2000 756.25–5875 1250 (83.1)
^NB: Indicated n – participants who indicated they did spend money on that item. Total who indicated spending money in last 3 months of life is n = 
1145 (76.1%); total missing data n = 359 (23.9%).
+Reported n – participants who reported the amount they spent on that item – for ‘one-off expenses’ respondents reported up to three expenses, 
which were totalled.
A large proportion of missing data is likely to be systematic, rather than missing due to incomplete reporting, as participants were not asked to 
indicate if they had not spent money.
aOnly those who reported spending money were included.
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bespoke survey with a census sample, thereby overcoming 
limitations of other estimates of carer contributions, and 
consequently the economic value of informal care, within 
the UK which have utilised secondary data.
Some post-bereavement surveys of quality of care 
have achieved response rates of 39%–46%.37,38 Our sur-
vey, which was arguably more cognitively demanding 
and of a potentially more sensitive nature due to the level 
of care-giving detail required, reached 28.5% participa-
tion. Furthermore, comparisons between participants, 
decliners and non-responders indicate that our sample 
was representative of the general population, with only 
minor differences, which may be partially accounted for 
by the self-selecting nature of self-report surveys. 
However, there may be potential bias in reported care-
giving by targeting only relatives who reported a death, 
as they may have provided different support compared to 
non-relatives.
A lot of palliative care research and economic evalua-
tions rely on retrospective recall and this is also a limita-
tion of this study. Retrospective recall can introduce bias 
due to inaccuracy in reporting past events, selective mem-
ory of the events and double counting or joint production 
of tasks – where tasks completed simultaneously are 
reported several times under multiple headings.39 While it 
is in principle possible to control for joint production to a 
certain extent during analyses,27,40 we added to the survey 
the instruction to participants not to count any ask twice in 
order to minimise this type of bias at source. Due to these 
effects, the data we report on hours of care may be inflated, 
but to not include certain aspects of care at all to mini-
mise the risk of joint production would involve under- 
estimation.40 We also tried to overcome bias by being 
specific about the time frame that tasks were completed, 
referring to a typical week during the last 3 months of life. 
However, at end of life few weeks are ‘typical’ and as 
such challenging for some participants to conceptualise 
and report.  Retrospective data collection does have disad-
vantages, but it does elicit more complete data compared 
with other methods such as diaries.39 Furthermore, these 
limitations should be weighed against the advantage of 
obtaining population-level data for an ‘anchored’ time 
period, rather than alternative methods which may have 
involved a much smaller, resource intensive, less repre-
sentative sample which would probably include data that 
vary in time relative to death.
Future research
This article provides a national census overview of cancer 
care-giving. Further analyses will consider the socio-
demographic patterns of care-giving, the impact of care on 
carers’ well-being and estimate the full economic value of 
end-of-life care provided by family carers of people with 
cancer comparing different methods for estimation.
We hope that the results of this study will form the basis 
for further national and international research comparing 
contribution and costs at end of life for other disease 
groups and other countries.
Conclusion
The contributions by informal care-givers of cancer 
patients within the UK may be higher than estimates previ-
ously indicated given that we report 69:30 median hours of 
care compared to previous research based on 15–24.5 h. 
This study has yielded a unique data set which will allow, 
for the first time, estimates of the full economic value of 
family care-giving for cancer patients at end of life based 
on population-level data within the UK.
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